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In June, I heard on the news about the world’s first
stem cell medication. The news said that a cardiac stem
cell therapy was expected to be approved for use at
hospitals. The approval will be the first of its kind in
the world to allow the use of this form of treatment.
The nation’s drug safety agency said that a stem cell
medication for treating heart attack victims, passed all
the required safety and quality tests. The vendor said
that the cardiac stem cell therapy could improve
ventricular contraction in patients with refractory post-
infarct heart failure. They also said that the phase Ⅲ
study is underway on the stem cell therapy for recovery
of brain [1].  
Before Dr. Woo-Suk Hwang made ethical problems
in his research, the stem cell therapy had had a high
public attention 5 years ago. The hard controversy
about ethical problems about embryonic stem cell and
the intangible achievement led to draw public attention
away from stem cell therapy. However, many efforts
have been made to use the stem cells driven from
umbilical cord blood or bone marrow instead of
embryonic stem cell. Somatic cells, such as fibroblasts
extracted from the patient’s own body, can be
reprogrammed to pluripotent stem cells by the
introduction of transcription factors. These induced
pluripotent stem cells are then differentiated to specific
neuron types for transplantation with this technology.
Patient-specific cells can be produced without the need
for immunosuppressive treatment after transplantation.
Then, the ethical issue with the use of human
embryonic stem cells can be avoided [2]. Results of
many basic researches bring us much closer to the day
when clinical grade stem cells might be available. Stem
cell therapy offers a remarkable potential for the
recovery of brain function after stroke, and treatment of
stroke using stem cell is a challenge that is worthy of
high expectations. Nowadays, we can easily find out a
lot of researches about stem cell for stroke recovery
from Google or Pubmed search engine.
The delivery of stem cell to targeting an area is the
cause that neurointerventionists should be concerned
about the stem cell therapy in stroke. There are
multimodal delivery methods from stereotactic
injection to intra-arterial routes. In view of the results
so far achieved, intra-arterial delivery of stem cells is
performed via the catheter that is traced though the
feeding artery to the target area. This method will have
a chance to take up as a commercialize method, and
can have benefits than other delivery methods.
Stereotactic injection is more invasive than intra-
arterial delivery. In addition, targeted intra-arterial
transplantation of stem cells to the injured brain is more
effective than intravenous administration [3]. Intra-
arterial delivery can be disseminated into specific
affected areas of the brain through the arterial system.
Delivered stem cells differentiate into neurons, and
migrate toward the ischemic lesion in brain [4]. There
is growing evidence that stem cells can induce
functional improvement by mechanisms other than
neuronal replacement. Products from transplanted stem
cells can induce modulation of inflammation,
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The catheterization safely in intracranial arteries is the
unique business of neurointerventionists. Therefore, I
think that neurointerventionists are most suitable to
perform the intra-arterial injection of stem cell to a
lesion in brain. 
However, stem cell therapy is not always wonderful,
and is just beginning to be translated into the clinical
realm. In order to apply into clinical fields, several
items have to be investigated. Most importantly, the
safety and efficacy should be confirmed. It should be
proved whether intra-arterial injection of neural stem
cells using a catheter technique causes microembolic
strokes or not. The risk for tumor formation also should
be eliminated. To bring the stem cells therapy much
closer to clinical applications, several clinical studies
using intra-arterial infusion of non-NSCs or MSCs in
patients  with  stroke  are  ongoing  or  planned
(www.clinicaltrials.gov). 
It is certain that the stem cell therapy for brain
recovery is just beginning to be translated into the
clinical realm and we are entering a new era in which
neurointerventionist can work. In order to play a
leading role in stem cell therapy, we should be
concerned about this item and actively participate in
the stage of basic and clinical research. 
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